Comfort Systems USA Inc vs Repligen Corporation Common Stock — how do they compare? Comfort Systems USA Inc trades at $1,516.2 (market cap $57.25B), while Repligen Corporation Common Stock trades at $178.18 (market cap $11.14B). The key difference: Comfort Systems USA Inc is far larger — about 5.1× Repligen Corporation Common Stock's market cap, and Comfort Systems USA Inc pays a 0.22% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Comfort Systems USA Inc for 42 Days and Repligen Corporation Common Stock for 0 Days on average.
| FIX | RGEN | |
|---|---|---|
Market Cap | $57.25B | $11.14B |
Volume | 459,246 | 1,259,263 |
Sector | Industrials | Health |
52-Week High | $2.07K | $194.57 |
52-Week Low | $790.72 | $102.87 |
Typical Hold Time | 42 Days | 0 Days |
Enterprise Value | $55.72B | $11.02B |
Dividend Yield | 0.22% | — |
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,626.64, down 0.7% with bearish technical signals but strong fundamentals. The company demonstrates robust earnings momentum with three consecutive quarterly beats and impressive profitability metrics including 55.29% ROE. Recent acquisition of Hunt Electric expands Western electrical scale with $250M in annualized revenue. Technical indicators show bearish momentum with support at $1,611 and resistance at $1,687.
Outlook remains positive with analyst consensus price target of $2,080 representing 28% upside potential. Key opportunities include data center infrastructure demand and modular expansion, while risks involve project execution challenges and market volatility. The stock offers growth exposure to essential AI infrastructure services with strong institutional backing.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →